<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">790410</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2022.790410</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Morphological Phenotyping of Organotropic Brain- and Bone-Seeking Triple Negative Metastatic Breast Tumor Cells</article-title>
<alt-title alt-title-type="left-running-head">DeCastro et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Morphological Phenotyping of Tumor Cells</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>DeCastro</surname>
<given-names>Ariana Joy L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pranda</surname>
<given-names>Marina A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gray</surname>
<given-names>Kelsey M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Merlo-Coyne</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Girma</surname>
<given-names>Nathaniel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hurwitz</surname>
<given-names>Madelyn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuji</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1010739/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Stroka</surname>
<given-names>Kimberly M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/761919/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Fischell Department of Bioengineering</institution>, <institution>University of Maryland</institution>, <addr-line>College Park</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Biology</institution>, <institution>University of Maryland</institution>, <addr-line>College Park</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Epidemiology and Public Health</institution>, <institution>University of Maryland</institution>, <addr-line>Baltimore</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Marlene and Stewart Greenebaum Comprehensive Cancer Center</institution>, <institution>University of Maryland</institution>, <addr-line>Baltimore</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Biophysics Program</institution>, <institution>University of Maryland</institution>, <addr-line>College Park</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Center for Stem Cell Biology and Regenerative Medicine</institution>, <institution>University of Maryland</institution>, <addr-line>Baltimore</addr-line>, <addr-line>MD</addr-line>, <country>United&#x20;States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/601326/overview">Claudia Tanja Mierke</ext-link>, Leipzig University, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/267731/overview">Virginia Espina</ext-link>, George Mason University, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1330189/overview">Shreyas S. Rao</ext-link>, University of Alabama, United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kimberly M. Stroka, <email>kstroka@umd.edu</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>790410</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 DeCastro, Pranda, Gray, Merlo-Coyne, Girma, Hurwitz, Zhang and Stroka.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>DeCastro, Pranda, Gray, Merlo-Coyne, Girma, Hurwitz, Zhang and Stroka</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Triple negative breast cancer (TNBC) follows a non-random pattern of metastasis to the bone and brain tissue. Prior work has found that brain-seeking breast tumor cells display altered proteomic profiles, leading to alterations in pathways related to cell signaling, cell cycle, metabolism, and extracellular matrix remodeling. Given the unique microenvironmental characteristics of brain and bone tissue, we hypothesized that brain- or bone-seeking TNBC cells may have altered morphologic or migratory phenotypes from each other, or from the parental TNBC cells, as a function of the biochemical or mechanical microenvironment. In this study, we utilized TNBC cells (MDA-MB-231) that were conditioned to metastasize solely to brain (MDA-BR) or bone (MDA-BO) tissue. We quantified characteristics such as cell morphology, migration, and stiffness in response to cues that partially mimic their final metastatic niche. We have shown that MDA-BO cells have a distinct protrusive morphology not found in MDA-P or MDA-BR. Further, MDA-BO cells migrate over a larger area when on a collagen I (abundant in bone tissue) substrate when compared to fibronectin (abundant in brain tissue). However, migration in highly confined environments was similar across the cell types. Modest differences were found in the stiffness of MDA-BR and MDA-BO cells plated on collagen I vs. fibronectin-coated surfaces. Lastly, MDA-BO cells were found to have larger focal adhesion area and density in comparison with the other two cell types. These results initiate a quantitative profile of mechanobiological phenotypes in TNBC, with future impacts aiming to help predict metastatic propensities to organ-specific sites in a clinical setting.</p>
</abstract>
<kwd-group>
<kwd>cell migration</kwd>
<kwd>cell morphology</kwd>
<kwd>tumor cells</kwd>
<kwd>cell mechanical characterization</kwd>
<kwd>focal adhesions</kwd>
</kwd-group>
<contract-num rid="cn001">Career Award at the Scientific Interface</contract-num>
<contract-num rid="cn002">1757745</contract-num>
<contract-num rid="cn003">Clark Doctoral Fellowship Graduate Student Summer Research Fellowship from the UMD Graduate School Fischell Fellowship in Biomedical Engineering Ann G. Wylie Fellowship</contract-num>
<contract-sponsor id="cn001">Burroughs Wellcome Fund<named-content content-type="fundref-id">10.13039/100000861</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">National Science Foundation<named-content content-type="fundref-id">10.13039/100000001</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">University of Maryland<named-content content-type="fundref-id">10.13039/100008510</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Breast cancer organotropic metastasis is the non-random pattern of breast cancer cells metastasizing to organs such as the bone, lung, liver, and brain (<xref ref-type="bibr" rid="B18">Gao et&#x20;al., 2019</xref>). The &#x201c;seed and soil theory&#x201d; hypothesizes that the cancer cells (seeds) have a favorable relationship with certain environments (soil) (<xref ref-type="bibr" rid="B17">Fokas et&#x20;al., 2007</xref>). In support of this theory, a study done in 886 breast cancer patients showed that 38.9% of patients with triple negative breast cancer (TNBC) developed metastases to the bone, while 25.2% of TNBC patients developed metastases to the central nervous system (<xref ref-type="bibr" rid="B8">Bartmann et&#x20;al., 2017</xref>). Further, a systematic literature review of 96 studies in the EMBASE and MEDLINE data bases found that TNBC was associated with a shorter time to brain metastasis compared to luminal subtypes (hormone receptor positive) (<xref ref-type="bibr" rid="B25">Koniali et&#x20;al., 2020</xref>).</p>
<p>The gold standard for treating TNBC is neoadjuvant therapy, which includes chemotherapy prior to invasive surgery, though there is still a high chance of relapse within 5&#xa0;years (<xref ref-type="bibr" rid="B30">Medina et&#x20;al., 2020</xref>). This disease has a higher incidence rate in younger (<xref ref-type="bibr" rid="B37">Partridge et&#x20;al., 2016</xref>) and African American women (<xref ref-type="bibr" rid="B44">Scott et&#x20;al., 2019</xref>). Unfortunately, African Americans are less likely to be diagnosed with localized cancer, a phase which is easier and more successfully treated (<xref ref-type="bibr" rid="B28">Lisovicz et&#x20;al., 2008</xref>). There is a critical need to diagnose this subtype of breast cancer at an earlier rate, especially for the African American community, in order to increase chances of early, and more successful treatment. It is possible that a better understanding of the morphological and biomechanical cell phenotypes associated with organotropic TNBC will lead to improved future treatments and reduction of this health disparity.</p>
<p>One factor that may contribute to organotropic TNBC metastasis is the tumor cell&#x2013;microenvironment interactions. MDA-MB-231&#x20;brain-seeking cells have been shown to interact with astrocytes at the blood-brain barrier, leading to activation of the immune response which contributed to chemoresistance and tumor growth (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2016</xref>). Further, we have shown that secreted factors from astrocytes alter MDA-MB-231 morphology and 2D migration (<xref ref-type="bibr" rid="B46">Shumakovich et&#x20;al., 2017</xref>). Other studies have explored MDA-MB-231 behavior in bone-related microenvironments. Blocking CXCL12, a chemokine involved in hematopoietic stem cell homing to bone marrow, reduced MDA-MB-231 migratory behavior, and metastasis to the lung and lymph-node. Therefore, there is speculation that CXCL12 chemokine could be involved in breast cancer cell homing to the bone (<xref ref-type="bibr" rid="B34">M&#xfc;ller et&#x20;al., 2001</xref>). Bone-seeking MDA-MB-231 cells have also been shown to overexpress parathyroid hormone protein (PTH-rP) which regulates bone remodeling (<xref ref-type="bibr" rid="B22">Hayman et&#x20;al., 1991</xref>; <xref ref-type="bibr" rid="B59">Yin et&#x20;al., 1999</xref>).</p>
<p>In addition to understanding the mechanisms behind organotropic metastasis, it is equally important to be able to identify unique characteristics of organotropic breast cancer cells that could distinguish them in a heterogeneous tumor cell population. An unanswered question is whether or not organotropic cells can be identified (or distinguished) by their physical characteristics, such as morphology, migration, and mechanical properties. One study isolated single cell clones of the parental MDA-MB-231 cell line, determined that some of these clonal lines had a unique cell morphology, and showed that certain clones were able to establish large secondary tumors in the lungs while others were only slightly tumorigenic; the degree of tumorigenicity and metastatic capability was similar among single cell clones with the same morphology (<xref ref-type="bibr" rid="B56">Wu et&#x20;al., 2020</xref>). A similar study has been done in pancreatic cancer cells and showed that cells with morphological heterogeneity were more prevalent in secondary lung tumors, compared to primary tumor cells (<xref ref-type="bibr" rid="B57">Wu et&#x20;al., 2015</xref>). Identifying the unique physical characteristics of organotropic tumor cells may have potential application in diagnosing metastatic risk of cancer patients and long-term novel therapeutic developments to reduce cancer disease progression. In this study, we used TNBC cell lines (MDA-MB-231) that have been conditioned to metastasize preferentially to brain or bone tissue (<xref ref-type="bibr" rid="B60">Yoneda et&#x20;al., 2001</xref>), with a goal of building a profile of phenotypic characteristics that could distinguish these subtypes in a heterogeneous tumor cell population.</p>
<p>Brain and bone tissue have distinct microenvironments. According to the seed and soil theory, components of the microenvironment such as extracellular matrix composition, and mechanical cues may play a role in organotropic metastasis. To form secondary tumors in brain tissue, the metastasizing cancer cells may take a route across the blood brain barrier (BBB), which is composed of brain endothelial cells and supported by astrocytes and pericytes, which help maintain homeostasis and regulate transport into the brain perivascular space (<xref ref-type="bibr" rid="B1">Abbott and Yusof, 2010</xref>). Breast cancer cells also must navigate the basement membrane of brain microvasculature, which is mainly composed of collagen IV, laminin, fibronectin, and other proteins. Furthermore, brain tissue contains non-fibrillar collagens types IV and VI, as well as hyaluronic acid and other proteins (<xref ref-type="bibr" rid="B3">Ananthanarayanan et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B26">Lau et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B19">George and Geller, 2018</xref>), and is on the order of &#x223c;1&#xa0;kPa in stiffness (<xref ref-type="bibr" rid="B39">Rao et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B4">Antonovaite et&#x20;al., 2018</xref>). Collagen I does not contribute to the brain tissue mechanics due to its low concentration (<xref ref-type="bibr" rid="B27">Linka et&#x20;al., 2021</xref>). On the other hand, the bone microenvironment is composed of an extracellular matrix mainly composed of collagen I, which enhances differentiation, adhesion, proliferation, and migration (<xref ref-type="bibr" rid="B43">Schor, 1980</xref>; <xref ref-type="bibr" rid="B42">Schor et&#x20;al., 1980</xref>). Collagen I is interspaced with inorganic hydroxyapatite (<xref ref-type="bibr" rid="B2">Alford et&#x20;al., 2015</xref>), other noncollagenous proteins, cells including osteoblasts and osteoclasts that regulate bone remodeling (<xref ref-type="bibr" rid="B11">Brook et&#x20;al., 2018</xref>), and a vascular network with endothelial cells lining the lumen surface (<xref ref-type="bibr" rid="B54">Watson and Adams, 2018</xref>). Tumor cells in this environment would have to navigate a stiffer matrix, as mature bone tissue has a Young&#x2019;s and shear modulus in the GPa range (<xref ref-type="bibr" rid="B33">Mulder et&#x20;al., 2008</xref>) and bone marrow tissue has a stiffness range of 0.3&#x2013;25&#xa0;kPa (<xref ref-type="bibr" rid="B7">Barney et&#x20;al., 2016</xref>). The differing mechanical properties and protein composition of brain versus bone motivate questions about whether brain-seeking and bone-seeking breast tumor cells display different functionally-relevant behaviors, such as morphology and migration, in brain versus bone tissue.</p>
<p>Previous studies have already explored some distinguishing characteristics of the MDA-MB-231&#x20;brain-seeking (MDA-BR) and bone-seeking (MDA-BO) clones. A proteomic study found that the MDA-BR clones displayed alterations in pathways related to cell signaling, cell cycle, metabolism and extracellular matrix remodeling compared to the parental MDA-MB-231 (MDA-P) clone (<xref ref-type="bibr" rid="B16">Dun et&#x20;al., 2015</xref>). Yoneda <italic>et&#x20;al.</italic> showed that MDA-BO cells have a higher production (compared to MDA-P and MDA-BR cells) of the hormone PTH-rP, which plays a role in the development of bone metastases (<xref ref-type="bibr" rid="B60">Yoneda et&#x20;al., 2001</xref>). MDA-BR cells also have higher expression of matrix metalloproteinases (MMPs) 1 and 9 mRNA levels compared to the MDA-P and MDA-BO cells (<xref ref-type="bibr" rid="B47">Stark et&#x20;al., 2007</xref>). Furthermore, one study showed that cell adhesion on brain- and bone-like extracellular matrices may be able to distinguish the organ-seeking clone subpopulations and predict metastatic risk (<xref ref-type="bibr" rid="B6">Barney et&#x20;al., 2015</xref>). These previous studies have served as the motivation to further explore cell phenotypic characteristics that could help to identify organ-seeking clones within heterogeneous tumor populations. Understanding these phenotypes could motivate the development of novel treatments to target tumor cell subsets and their preferred microenvironment as well as a method of diagnosing metastatic risk to specific organs in a clinical setting.</p>
<p>Here, we explored whether cell phenotypic characteristics such as morphology, cell migration, and mechanical properties may differ between organ-seeking clones. We show that MDA-BO clones have a smaller and more protrusive morphology that may be influenced by successive <italic>in&#x20;vitro</italic> passaging. Further, the MDA-BO clone has an altered chemokinetic migratory response on two-dimensional collagen I-coated substrates in comparison with MDA-BR and MDA-P cells. Finally, both the mechanical properties (i.e.,&#x20;Young&#x2019;s modulus) and cell morphological properties varied between the MDA-P, MDA-BO, and MDA-BR clones as a function of substrate stiffness. These unique clonal phenotypes provide further insights into the functional differences between brain- and bone-seeking metastatic tumor&#x20;cells.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Cell Culture</title>
<p>MDA-MB-231 parental (MDA-P), brain-seeking (MDA-BR), and bone-seeking (MDA-BO) clones were provided by Dr. Toshiyuki Yoneda in Osaka, Japan. Organ-seeking clones were developed in his lab using a protocol described previously (<xref ref-type="bibr" rid="B60">Yoneda et&#x20;al., 2001</xref>). Briefly, MDA-MB-231 cells were injected into mice and allowed to metastasize to the brain or bone. This process was repeated until a population that solely metastasizes to either the brain or the bone was established. Upon arriving in our lab, the cells were checked for authenticity using STR testing (Laragen, Inc.), and all three cell lines best matched the MDA-MB-231 line (see <xref ref-type="sec" rid="s10">Supplementary Material</xref> for full results provided by Laragen, Inc.). The cells were cultured in medium consisting of Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium (DMEM) supplemented with high glucose (ThermoFisher Scientific, Waltham, MA, United&#x20;States), 10% Fetal Bovine Serum (FBS; HyClone Characterized GE Healthcare, Pittsburgh, PA, United&#x20;States or ThermoFisher Scientific), and 1% Penicillin-Streptomycin 10,000&#xa0;U/ml. Cells were washed with Phosphate-Buffered Saline (PBS) (VWR, Radnor, PA, United&#x20;States), and detached with 0.25% Trypsin-EDTA (ThermoFisher Scientific). Cells were cultured at 37&#xb0;C, 50% humidity, and 5% CO<sub>2</sub>:95% air. Cells were passaged every 2&#xa0;days (up to passage 12) when about 80% confluency was reached. Unless otherwise noted, trials from different passages were pooled, while <xref ref-type="fig" rid="F2">Figure&#x20;2</xref> specifically assessed passage-dependence.</p>
</sec>
<sec id="s2-2">
<title>Phase Contrast Imaging and Measurement of Suspended and Adherent Cell Morphology</title>
<p>To assess the morphology of suspended (non-adherent) cells, a total of 4&#x20;&#xd7; 10<sup>5</sup> cells were plated into 6-well non-tissue culture treated plates (VWR) and imaged immediately. Ten-micron diameter (9.94&#x20;&#xb1; 1.01&#xa0;&#xb5;m according to manufacturer for specific batch) Envy Green fluorescent beads (Bangs Laboratories, Inc., Fishers, IN, United&#x20;States) were suspended in blank wells of the same plates to validate imaging and analysis based on the known diameter. For cells in suspension (and beads), images were modified in ImageJ for maximum brightness and contrast to achieve the sharpest contours. The image was then converted to binary black and white after thresholding. The ImageJ function to fill holes was applied and the ImageJ built in particle analyzer was used to analyze particles 300&#x2013;1,250 pixels<sup>2</sup> in area with circularity values of 0.65&#x2013;1 to eliminate any aggregates from analysis. To assess the morphology of adherent cells, 1&#x20;&#xd7; 10<sup>5</sup> cells were plated into 6-well tissue culture treated plates (VWR) and allowed to attach overnight. Phase contrast imaging was performed using a 20x objective. ImageJ was used to process images and quantify area, inverse aspect ratio, circularity, and solidity. Inverse aspect ratio is defined as the ratio of the minor axis to the major axis. Solidity is defined as the ratio of the area to the convex area. Circularity is the ratio of <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mn>4</mml:mn>
<mml:mi>&#x3c0;</mml:mi>
<mml:mi>A</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> to <italic>P</italic>
<sup>
<italic>2</italic>
</sup>, where <italic>A</italic> is the projected area of the cell in the image, and <italic>p</italic> is the perimeter of the&#x20;cell.</p>
</sec>
<sec id="s2-3">
<title>2D Migration Assays</title>
<p>For 2D cell migration experiments, cells were plated onto substrates coated with collagen I from rat tail (Sigma Aldrich, St. Louis), fibronectin from human plasma (Sigma Aldrich), or poly-d-lysine hydrobromide (PDL) (Sigma Aldrich). Collagen I and fibronectin were dissolved in PBS, and PDL was dissolved in sterile milliQ water. Twenty-four well glass bottom plates (MatTek, Ashland, MA) were coated with 300&#xa0;&#xb5;l (per well) of 20&#xa0;&#x3bc;g/ml of the varying protein solutions and incubated for 1&#xa0;h at 37&#xb0;C. Following incubation, wells with collagen and fibronectin were washed 3&#x20;times with PBS, while wells with PDL were washed 3&#x20;times with sterile milliQ water. After washing the substrates, 1&#x20;&#xd7; 10<sup>4</sup> cells were plated into each well. Cells were imaged and analyzed as described&#x20;below.</p>
</sec>
<sec id="s2-4">
<title>Microchannel Device Fabrication and Preparation</title>
<p>Microchannel devices were fabricated as we previously described in detail (<xref ref-type="bibr" rid="B5">Balzer et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B15">Doolin and Stroka, 2018</xref>). Once fabricated, the polydimethylsiloxane (PDMS) devices were sonicated in 100% ethanol (Pharmco) for 5&#xa0;min. The PDMS devices and 35&#xa0;mm by 75&#xa0;mm glass coverslips were rinsed with deionized water, followed with 100% ethanol, and then dried thoroughly with pressurized air. Both the PDMS devices and coverslips were plasma-treated using a plasma cleaner (Harrick Plasma, Ithaca, NY, United&#x20;States) and pressed together for irreversible bonding. 40&#xa0;&#x3bc;l of type I rat tail collagen (20&#xa0;&#x3bc;g/ml) solution was pipetted into each inlet and outlet of the device, the device was incubated for 1&#xa0;h at 37&#xb0;C, and then the device was washed two times by pipetting PBS into and out of all wells of the device. Meanwhile, cells growing in culture were washed with PBS, detached with 0.25% Trypsin-EDTA (ThermoFisher Scientific), centrifuged, and resuspended to a final concentration of 1&#x20;&#xd7; 10<sup>5</sup>&#xa0;cells/25&#xa0;&#xb5;l. Twenty-five microliters of cell suspension were added to the cell inlet, and the device was incubated for 5&#xa0;min at 37&#xb0;C for initial cell seeding. Excess liquid was removed from the cell inlet and outlet, and 50&#xa0;&#xb5;l of serum-free media was added to the bottom inlet, along with the 2 lower inlets of the upper channel. Fifty microliters of serum-full media were added to the top-most inlet of the main upper channel.</p>
</sec>
<sec id="s2-5">
<title>Polyacrylamide Gel Preparation</title>
<p>Polyacrylamide (PA) gels (&#x223c;80&#xa0;&#x3bc;m thick) were formed using a method initially described by Wang and Pelham (<xref ref-type="bibr" rid="B53">Wang and Pelham, 1998</xref>) and described in our previous publications (<xref ref-type="bibr" rid="B50">Stroka and Aranda-Espinoza, 2009</xref>; <xref ref-type="bibr" rid="B49">Stroka and Aranda-Espinoza, 2011</xref>; <xref ref-type="bibr" rid="B52">Stroka et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B21">Hamilla et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B20">Gray et&#x20;al., 2019</xref>) on 22&#x20;&#xd7; 22&#xa0;mm coverslips (ThermoFisher Scientific). PA gels were coated with 50&#xa0;&#x3bc;g/ml collagen I using sulfo-SANPAH activation, also as previously described in our work (<xref ref-type="bibr" rid="B50">Stroka and Aranda-Espinoza, 2009</xref>; <xref ref-type="bibr" rid="B49">Stroka and Aranda-Espinoza, 2011</xref>; <xref ref-type="bibr" rid="B52">Stroka et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B21">Hamilla et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B20">Gray et&#x20;al., 2019</xref>). A total of 1&#x20;&#xd7; 10<sup>5</sup> cells was plated onto each gel. For AFM experiments on gels, coverslips containing gels were secured to 50&#xa0;mm AFM grade glass bottom dishes (VWR).</p>
</sec>
<sec id="s2-6">
<title>Atomic Force Microscopy</title>
<p>The Young&#x2019;s modulus of tumor cells on PA gels (as described in the section above) or on glass (50&#xa0;mm AFM grade glass bottom dishes, VWR) was measured using atomic force microscopy (AFM). After 1&#xa0;day in culture, AFM was performed on live cells with the stage heated to 37&#xb0;C. AFM was performed using an Asylum MFP-3D-BIO Atomic Force Microscope with TR400PB(L) probes (Asylum Research) as previously described (<xref ref-type="bibr" rid="B20">Gray et&#x20;al., 2019</xref>). Asylum&#x2019;s &#x201c;Get Real&#x201d; approach was used to measure the spring constant and inverse optical lever sensitivity of TR400PB(L) probes via the Sader method and thermal noise method, respectively. The average spring constant of the cantilevers was within a factor of 1.33 to Asylum&#x2019;s nominal value of 0.02&#xa0;N/m and all within the nominal range of 0.01&#x2013;0.05&#xa0;N/m. One 100-curve force map covering a 5&#xa0;&#x3bc;m<sup>2</sup> area was collected for each cell using a 2&#xa0;&#x3bc;m force distance, a 1&#xa0;V trigger point (approximately 1.35&#xa0;nN), and a scan rate of 0.99&#xa0;Hz. The Hertz model was used to fit the force curves within Asylum&#x2019;s Igor Pro-based software using the equation <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mn>4</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
<mml:mo>&#x2217;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>&#x3c5;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2217;</mml:mo>
<mml:msqrt>
<mml:mi>r</mml:mi>
</mml:msqrt>
<mml:mo>&#x2217;</mml:mo>
<mml:msup>
<mml:mi>&#x3b4;</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mn>3</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msup>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula> where <italic>&#x3b4;</italic> is the measured indentation of the sample and the Young&#x2019;s modulus <italic>E</italic> was the fitting parameter. The Poisson&#x2019;s ratio <italic>&#x3c5;</italic> of the sample was assumed to be 0.45 and the tip radius of curvature <italic>r</italic> was approximately 30&#xa0;nm. Three biological replicates were performed in which three cells per condition per trial were measured (<italic>n</italic>&#x20;&#x3d; 9 cells total, or 900 force curves per condition).</p>
</sec>
<sec id="s2-7">
<title>Cell Migration Tracking and Data Analysis</title>
<p>Images were acquired on an Olympus IX83 microscope (Olympus, Center Valley, PA, United&#x20;States) using a 10x objective. To maintain the cell viability during imaging, a chamber calibrated to 37&#xb0;C, 50% humidity, and 5% CO<sub>2</sub>:95% air was used on the microscope stage. Images were taken at 5-min intervals (as specified in figure captions). On the following day, a collection of phase contrast images was taken using a 20x objective. 2D and confined cell migration tracking parameters were determined as described previously (<xref ref-type="bibr" rid="B46">Shumakovich et&#x20;al., 2017</xref>). Cells were tracked over 390&#x2013;750&#xa0;min for 2D assays and approximately 720&#xa0;min for confinement assays. Cells that were migrating out of the frame or dividing were not tracked. Mean squared displacement (MSD) was calculated as previously described (<xref ref-type="bibr" rid="B50">Stroka and Aranda-Espinoza, 2009</xref>; <xref ref-type="bibr" rid="B46">Shumakovich et&#x20;al., 2017</xref>). Briefly, the average of the square of the distance traveled was calculated as the MSD between each pair of points. The MSDs were averaged for every time interval and plotted vs. the corresponding time interval. The diffusion coefficient was acquired by fitting MSD vs. time plots to the Langevin-type equation <inline-formula id="inf3">
<mml:math id="m3">
<mml:mrow>
<mml:msup>
<mml:mi>r</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>4</mml:mn>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3c0;</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>, where <italic>D</italic> is the diffusion coefficient, <inline-formula id="inf4">
<mml:math id="m4">
<mml:mrow>
<mml:msup>
<mml:mi>r</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> is the MSD, <italic>t</italic> is time, and <inline-formula id="inf5">
<mml:math id="m5">
<mml:mi>&#x3c4;</mml:mi>
</mml:math>
</inline-formula> is the persistence&#x20;time.</p>
</sec>
<sec id="s2-8">
<title>Immunofluorescent Staining of Focal Adhesions</title>
<p>Glass-bottom dishes were coated with 20&#xa0;&#x3bc;g/ml collagen I or a 4:1 ratio of 20&#xa0;&#x3bc;g/ml collagen IV and 20&#xa0;&#x3bc;g/ml fibronectin and incubated at 37&#xb0;C for 1&#xa0;hour, and then washed at least two times with PBS. A total of 1&#x20;&#xd7; 10<sup>4</sup> cells were plated into the dishes and incubated overnight. The next day, cells were fixed with 3.7% formaldehyde (Millipore Sigma) for 10&#xa0;min at room temperature. Following three 5-min PBS washes, the cells were permeabilized with 1% Triton-X 100 (Millipore Sigma) at room temperature. The cells were washed 2&#x20;times with PBS for 5&#xa0;min each. The samples were blocked in 2.5% bovine serum albumin (Millipore Sigma) for 1&#xa0;h at room temperature. Phospho-Paxillin (Tyr118) antibody (Rabbit, monoclonal antibody, Cell Signaling Technology &#x23;2541) or Phospho-FAK (Tyr 397) (Rabbit, monoclonal antibody, and Invitrogen &#x23;700255) was diluted with 1% bovine serum albumin at a 1:100 ratio and added to the cells. The primary antibodies were incubated with cells overnight at 4&#xb0;C and samples were washed twice the next day with PBS for 5&#xa0;min per wash. The samples were then blocked with 2.5% BSA for 1&#xa0;h at room temperature. Cells were then incubated with 1:500 phalloidin (Alexa Fluor 488, Life Technologies &#x23;A12379), 1:2,500 Hoechst (Hoechst 33,342, trihydrochloride, trihydrate, Life Technologies &#x23;H3570, and 1:200 secondary antibody (Alexa Fluor 568 goat anti-rabbit (H &#x2b; L) &#x23;A11011) for 1&#xa0;h at room temperature. Finally, samples were washed 3&#x20;times with PBS for 5&#xa0;min each and stored at 4&#xb0;C until imaging.</p>
</sec>
<sec id="s2-9">
<title>Confocal Microscopy and Focal Adhesion Analysis</title>
<p>Fluorescent images were acquired using a FV 3000 RS Olympus Laser Scanning Confocal Microscope (Olympus, Center Valley, PA, United&#x20;States) using a 60x oil objective. Vertical Z-stack images were taken with the appropriate filters using the FluoView FV31S-SW software. Image brightness was adjusted separately for each channel to optimize visibility, but adjustments were done consistently across image sets. For PY-paxillin and phospho-FAK analysis, ImageJ was used to analyze focal adhesion size and count using images at the cell-substrate interface. Images were converted to 8&#x2013;bit and background was subtracted at 50 pixels. Auto threshold was determined by the software and the &#x201c;analyze particles&#x201d; plug-in was used to determine focal adhesion area and count. A minimum focal adhesion size of 4.14&#xa0;&#x3bc;m was considered to prevent counting background staining. CellProfiler, a cell image analysis software, and was used to calculate the total cell areas from the actin images. Focal adhesion density was calculated by dividing the number of focal adhesions in a cell image by the total cell area in the corresponding&#x20;image.</p>
</sec>
<sec id="s2-10">
<title>Statistics</title>
<p>GraphPad (GraphPad, San Diego, CA) was used for all statistical analyses. Normality was tested using the D&#x2019;Agostino-Pearson normality test (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>). If the data were found to follow or partially follow (e.g., where some groups in the set were normally distributed, while some were not) a normal distribution, a one-way ANOVA or two-way ANOVA was performed to determine statistical significance. If the data did not follow a normal distribution, a Kruskal Wallis test followed by a Dunn&#x2019;s multiple comparison was used. Statistical significance was determined by using a cutoff of <italic>p</italic> value less than 0.05. At least three independent trials were conducted for each experiment. Cells from all three experiments were pooled between passages 6&#x2013;12 for all experiments. A ROUT test was used to identify outliers in the focal adhesion expression data set. The data with outliers excluded were used to perform the statistical analysis as previously described.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>MDA-BO Cells Have Smaller Area and Diameter in Suspension</title>
<p>Breast tumor cells circulate in a suspended state in the blood stream during the metastatic cascade, prior to adhesion to the vascular endothelium (<xref ref-type="bibr" rid="B31">Mentis et&#x20;al., 2020</xref>). Circulating tumor cells are associated with increased risk of metastasis and lower progression-free and overall survival in breast cancer patients (<xref ref-type="bibr" rid="B10">Bidard et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B41">Riebensahm et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B13">Cristofanilli et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B36">Park et&#x20;al., 2020</xref>). We first questioned whether the three breast tumor cell clones had different sizes in suspension. First, to validate morphological analysis of cells in suspension, we added a suspension of 10&#xa0;&#xb5;m diameter beads to a glass-bottom dish, imaged the beads using phase contrast microscopy, and used the analyze particles plugin in ImageJ to characterize size of the beads (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). Bead diameters using our method were measured to be 11.8&#x20;&#xb1; 1.25&#xa0;&#xb5;m, while bead area was 108.4&#x20;&#xb1; 16.1&#xa0;&#xb5;m<sup>2</sup>. Hence, we moved on to evaluate the size of breast tumor cells in suspension by plating parental and organ-seeking clones into non-treated tissue culture plates and imaging the cells using phase contrast microscopy (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). MDA-BO cells were found to have a smaller median diameter (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>) and area (<xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>) when compared to the MDA-BR and MDA-P cells. It is important to note that the cell populations are highly heterogenous in size, even in suspension, as evidenced by the relatively large interquartile ranges of the data (<xref ref-type="fig" rid="F1">Figures 1B,C</xref>). It is possible that differences in cell cycle stage may have contributed to the heterogeneity of suspended cell size, and/or that cells, even in the same cell cycle phase, are innately heterogeneous in&#x20;size.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Morphology of suspended parental, brain-seeking, and bone-seeking MDA-MB-231s. <bold>(A)</bold> Phase contrast images of MDA-P, MDA-BR, and MDA-BO cells in suspension. Scale bar represents 50&#xa0;&#x3bc;m. <bold>(B)</bold> Diameter measured by ImageJ.&#x20;<bold>(C)</bold> Area of suspended MDA-P, MDA-BR, and MDA-BO cells based on diameter. Box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range. &#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.05. &#x2a;&#x2a;&#x2a;&#x2a; indicates a <italic>p</italic>&#x20;&#x3c; 0.0001. Each column of data is from N &#x3e; 1,277 cells pooled from at least 3 independent experiments. The data in this figure were tested for normality using the D&#x2019;Agostino and Pearson test and found to be not normally distributed. A Kruskal Wallis test and a Dunn&#x2019;s multiple comparison test was performed to determine significance.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>MDA-BO Cells&#x2019; Morphology Is Modestly Altered Following Successive <italic>in&#x20;vitro</italic> Passaging</title>
<p>To evaluate the effects of cell passage on the morphology of adherent organ-seeking clones, we plated cells from different passages onto tissue culture treated 6-well plates. Cells were imaged using phase contrast microscopy (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>), and cell morphological features, including area (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>), inverse aspect ratio (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>), circularity (<xref ref-type="fig" rid="F2">Figure&#x20;2D</xref>), and solidity (<xref ref-type="fig" rid="F2">Figure&#x20;2E</xref>) were analyzed. We found that, for all passages the area, circularity, and solidity of the MDA-BO cells were significantly smaller than the MDA-P cells (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). Further, the MDA-BO cells significantly decreased in area, circularity, and solidity (<xref ref-type="fig" rid="F2">Figures 2B,D,E</xref>) between passages 6 and 12. This same trend was not seen in the MDA-P and MDA-BR cells. Inverse aspect ratio (a proxy for cell elongation) was mostly consistent across passages and cell clones (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). Overall, these qualitative and quantitative results indicate that the MDA-BO cells are smaller, less circular, and more protrusive than their MDA-P or MDA-BR cell counterparts, and that these morphological features are modestly altered over passage.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effects of passage number on cell morphology. <bold>(A)</bold> Phase contrast images of MDA-P, MDA-BR, and MDA-BO cells at Passage 6 (P6) and Passage 12 (P12). Scale bars represent 100&#xa0;&#x3bc;m (in zoomed out images) or 50&#xa0;&#x3bc;m (in zoomed insets). Also shown are quantification of cell <bold>(B)</bold> area, <bold>(C)</bold> inverse aspect ratio, <bold>(D)</bold> circularity, and <bold>(E)</bold> solidity as a function of passage number. Box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range. &#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.05. &#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.01. &#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.001. &#x2a;&#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.0001. Each column of data is from N &#x3e; 190 cells pooled from at least 3 independent experiments. The data were tested for normality using the D&#x2019;Agostino and Pearson test. Data for area, inverse aspect ratio, and solidity did not follow a normal distribution, and hence a Kruskal Wallis test and a Dunn&#x2019;s multiple comparison test were performed to determine significance for those data. Data for circularity partially followed a normal distribution, and hence a two-way ANOVA, and multiple comparison test was performed to determine significance for that data&#x20;set.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>MDA-BO Cells Migrate Over Larger Area During Chemokinesis on Collagen I</title>
<p>Morphological alterations in attached and suspended breast tumor cell clones motivated us to evaluate random migration (i.e.,&#x20;chemokinesis) on three different substrate coatings&#x2013;collagen I, fibronectin, and poly-d-lysine (PDL). Collagen I is an abundant protein in the bone extracellular matrix (source), while fibronectin is found in the brain basement membrane and extracellular matrix (source); both promote cell integrin-based adhesions. PDL promotes electrostatic interactions between cells and the substrate, thus presumably blocking integrin-based binding. Qualitative inspection of phase contrast images suggested that MDA-BO cells were more protrusive (less solid) on collagen I and on fibronectin (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Meanwhile, during chemokinesis, there were no statistically significant differences in migration speed between cell types on collagen I or fibronectin. On PDL, all cell types were migrating significantly slower compared to their corresponding cell types on collagen I substrate, while only the MDA-P and MDA-BO cells were moving slower compared to a fibronectin substrate (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). Meanwhile, on collagen I-coated substrates (but not fibronectin), MDA-BO cells had a higher mean squared displacement (MSD) over time, and diffusion coefficient compared to MDA-BR and MDP-P cells (<xref ref-type="fig" rid="F3">Figures 3C&#x2013;F</xref>). These results suggest that even though the MDA-BO <italic>speed</italic> was not different from the other clones, the MDA-BO cells covered a larger area over time while migrating, and hence were more <italic>persistent</italic>. Because we observed the largest differences in 2D chemokinetic migration between cell clones on collagen I, the subsequent confined migration, atomic force microscopy, substrate stiffness, and focal adhesion experiments used collagen I as the substrate.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>2D migratory characteristics on ECM binding proteins. <bold>(A)</bold> Phase contrast images of MDA-P, MDA-BR, and MDA-BO cells on Collagen I, Fibronectin, or PDL coated substrates. Scale bars represent 100&#xa0;&#x3bc;m (in zoomed out images) or 50&#xa0;&#x3bc;m (in zoomed insets). <bold>(B)</bold> Speed tracked for 360&#xa0;min at 5-min intervals. Groups with &#x23; on top are different from corresponding cell type on Fibronectin substrate with <italic>p</italic>&#x20;&#x3c; 0.001. Groups with $ on top are different from corresponding cell type on Collagen I substrate with <italic>p</italic>&#x20;&#x3c; 0.001. <bold>(C)</bold> Diffusion coefficient calculated from mean squared displacement (MSD) vs. time data (over 300&#xa0;min), as described in the Methods section. Also shown is mean MSD vs. time interval plots for migration on <bold>(D)</bold> Collagen I, <bold>(E)</bold> Fibronectin, and <bold>(F)</bold> PDL. In panel B, box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range; each column of data is from N &#x3e; 37 cells pooled from at least 3 independent experiments. Panel B data was tested for normality using the D&#x2019;Agostino and Pearson test and found to be not normally distributed. A Kruskal Wallis test and a Dunn&#x2019;s multiple comparison test was performed to determine significance.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Confined Migration Speed and Chemotactic Index do Not Vary Between Parental and Organ-Seeking Clones</title>
<p>Breast tumor cells experience confinement throughout the metastatic cascade, in migrating through ECMs, during intravasation and extravasation, and while migrating along anatomical features (<xref ref-type="bibr" rid="B5">Balzer et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B51">Stroka and Konstantopoulos, 2013</xref>). To mimic confinement, microchannel devices with widths varying from 3 to 50&#xa0;&#xb5;m were used to evaluate cell migration speed and chemotactic index (CI) in response to a chemotactic gradient (FBS) (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). MDA-P and MDA-BO cells generally migrated more persistently (<xref ref-type="fig" rid="F4">Figures 4B&#x2013;D</xref>) and slower (<xref ref-type="fig" rid="F4">Figures 4E&#x2013;G</xref>) in highly confined (3, 6, and 10&#xa0;&#xb5;m) channels. However, interestingly, that same trend was not observed in the MDA-BR cells, which had similar speeds and persistency across all channel widths.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Confined migratory characteristics of organ-seeking clones <bold>(A)</bold> Phase contrast images of an MDA-P cell migrating through a 10&#xa0;&#x3bc;m channel. Chemotactic indices were quantified for <bold>(B)</bold> MDA-P, <bold>(C)</bold> MDA-BR, and <bold>(D)</bold> MDA-BO for each channel width. Images were taken at 5-min intervals over 12&#xa0;h. Speed was quantified for <bold>(E)</bold> MDA-P, <bold>(F)</bold> MDA-BR, and <bold>(G)</bold> MDA-BO for each channel width for over 12&#xa0;h and at 5-min intervals. Box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range. &#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.05. &#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.01. &#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.001. &#x2a;&#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.0001. Each column of data is from N &#x3e; 190 cells pooled from at least 3 independent experiments. The data were tested for normality using the D&#x2019;Agostino and Pearson test and found to be normally distributed. A one-way ANOVA and multiple comparisons test were performed to determine significance these&#x20;data.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Organ-Seeking Clones Have Modest Differences in Stiffness on Soft and Stiff Substrates</title>
<p>Because the brain and bone-seeking clones target tissues with unique matrix stiffnesses, we hypothesized that one method these organ-seeking cells may use to determine a preferential environment is by sensing the environment&#x2019;s extracellular matrix stiffness. Further, we wanted to explore whether these clones altered their stiffness in response to the environment, perhaps as a mechanical mechanism that enhances their survival. We compared cells on collagen I-coated glass, which is in the GPa range of stiffness (similar to mature bone tissue), and on collagen I-coated polyacrylamide gels of intermediate stiffness (&#x223c;194&#xa0;kPa) or a stiffness similar to the brain microenvironment (&#x223c;1&#xa0;kPa). The polyacrylamide gels were fabricated, coated with collagen I, and seeded with cells. Atomic force microscopy (AFM) was performed on the cells in force mapping mode and Young&#x2019;s modulus was calculated by fitting the force vs. distance curves to the Hertz model, as described in the Methods section. MDA-BR and MDA-BO cells&#x2019; Young&#x2019;s moduli on glass were modestly larger in comparison with the respective cell clone on soft 1&#xa0;kPa gels (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). In addition, the MDA-BR cells had a lower stiffness on the 1kPa compared to the 194&#xa0;kPa (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). There were no differences in Young&#x2019;s modulus between the three cell types for any substrate stiffness.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Mechanobiological characteristics of MDA-P, MDA-BR, and MDA-BO cells on stiff and soft substrates <bold>(A)</bold> Phase contrast images of MDA-P, MDA-BR, and MDA-BO cells on glass, 194&#xa0;kPa, and 1&#xa0;kPa. Scale bars represent 100&#xa0;&#x3bc;m (in zoomed out images) or 50&#xa0;&#x3bc;m (in zoomed insets). <bold>(B)</bold> Young&#x2019;s modulus from atomic force microscopy of each cell type on glass, 194&#xa0;kPa, and 1&#xa0;kPa. Also shown are cell <bold>(C)</bold> area, <bold>(D)</bold> inverse aspect ratio, <bold>(E)</bold> circularity, and <bold>(F)</bold> solidity on each substrate. Box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range. &#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.01. Each column of data is from N &#x3e; 28 cells pooled from at least 3 independent experiments. See additional statistics in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. The data were tested for normality using the D&#x2019;Agostino and Pearson test. Data for Young&#x2019;s modulus followed a normal distribution for some groups, and hence a two-way ANOVA and multiple comparison test were performed to determine significance for those data. Data for morphology did not follow a normal distribution, and hence a Kruskal Wallis test and Dunn&#x2019;s multiple comparison test was performed to determine significance for those data&#x20;sets.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>MDA-BR and MDA-BO Cells Have a Distinct Morphology Compared to MDA-P Cells on Soft and Stiff Substrates</title>
<p>Since we had previously observed morphological differences between the clones on tissue culture plastic, we quantified whether there were differences in their morphology in response to substrate stiffnesses mimicking either the brain or bone environment. Qualitatively, we observed that all cell types became less spread on soft (1&#xa0;kPa) substrates (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). We found that the MDA-BO clones had the largest area on both the stiff polyacrylamide gel (&#x223c;194&#xa0;kPa) and soft polyacrylamide gel (&#x223c;1&#xa0;kPa) but the smallest area on glass (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>) when compared to MDA-P and MDA-BR clones. Further, the MDA-BO clones had the lowest circularity and solidity on all substrates (<xref ref-type="fig" rid="F5">Figures 5E,F</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). Meanwhile, the MDA-BR clones had similar areas to the MDA-P cells on the 1&#xa0;kPa substrate but had minor differences in the inverse aspect ratio, circularity, and solidity (<xref ref-type="fig" rid="F5">Figures 5D&#x2013;F</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). Notably, the MDA-BR cells had higher areas compared to the MDA-P cells on both glass and 194&#xa0;kPa. We note that another study comparing MDA-P and MDA-BR cells has reported a similar trend (<xref ref-type="bibr" rid="B35">Narkhede et&#x20;al., 2018</xref>). Furthermore, both MDA-P and MDA-BR cells had decreasing areas and increasing inverse aspect ratios as stiffness decreased. Finally, all cell types displayed increasing solidity as substrate stiffness decreased.</p>
</sec>
<sec id="s3-7">
<title>MDA&#x2013;BO Cells Have More Densely Distributed Focal Adhesions on Collagen I Substrate</title>
<p>A previous study has identified a subpopulation of MDA-MB-231s that has a high &#x3b1;5&#x3b2;1 integrin expression, which has been linked to having more prominent focal adhesion expression and higher invasion rates (<xref ref-type="bibr" rid="B32">Mierke et&#x20;al., 2011</xref>). Additional studies have also shown that MDA-BO and MDA-BR cells have higher &#x3b1;5&#x3b2;1 integrin expression (<xref ref-type="bibr" rid="B29">McFarlane et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B23">Jahangiri et&#x20;al., 2017</xref>). This motivated us to explore whether there were differences in focal adhesion phenotypes between the MDA-P, MDA-BO, and MDA-PR clones. We imaged PY-paxillin and phospho-FAK, along with F-actin, in cells on collagen I-coated substrates (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>). We then processed the images using FIJI and Cell Profiler to quantify the area, number of focal adhesions per cell, and density of focal adhesions marked by PY-paxillin or phospho-FAK (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). On the collagen I substrate, MDA-BO had a higher PY-paxillin focal adhesion area, count per cell, and density when compared to the other two cell lines (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>). Furthermore, MDA-BO cells had higher area of phospho-FAK rich focal adhesions compared to the MDA-P &#x26; MDA-BR cells, while the focal adhesion count per cell and density were similar (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Focal adhesions on Collagen I, and Collagen IV &#x2b; Fibronectin. <bold>(A)</bold> Confocal images of PY-paxillin and/or Phospho-FAK and Actin on Collagen I or Collagen IV &#x2b; Fibronectin substrates. Scale bar represents 10&#xa0;&#x3bc;m. Images are adjusted for best visibility. <bold>(B)</bold> Image processing procedure using FIJI and CellProfiler. Also shown are the area of focal adhesions (FAs), number of FAs per cell, and FA density (number of FAs normalized to cell area) for <bold>(C)</bold> PY-paxillin and Phospho-FAK on Collagen I. Box and whisker plots represent the minimum and maximum data points, the median, and the interquartile range. For FA area, each data point represents the area of an individual FA, and for FA number per cell or FA density, each data point is representative of one cell. &#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.05. &#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.01. &#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.001. &#x2a;&#x2a;&#x2a;&#x2a; indicates <italic>p</italic>&#x20;&#x3c; 0.0001. Each column of data is from N &#x3e; 53 cells pooled from at least 3 independent experiments. A ROUT test was used to identify outliers in the FA size and density data sets. The data with outliers excluded were used to perform the subsequent statistical analysis. The data was tested for normality using the D&#x2019;Agostino and Pearson test. Data for number of phospho-FAK FAs per cell and PY-paxillin FA density on collagen I followed a normal distribution for some groups, and hence a one-way ANOVA and multiple comparison&#x2019;s test were performed to determine significance. For all other measurements, the data were not normally distributed, and hence a Kruskal Wallis test and a Dunn&#x2019;s multiple comparison test were performed to determine significance.</p>
</caption>
<graphic xlink:href="fcell-10-790410-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Prior studies have shown that larger tumor cells with more protrusions metastasize more and have a greater ability to migrate through blood vessels to distant sites (<xref ref-type="bibr" rid="B48">Stoletov et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B58">Yankaskas et&#x20;al., 2019</xref>) suggesting that phenotypic differences between different cell clones may also be indicative of changes in their metastatic potential. Here, our work suggests that MDA-BO cells may be most distinguished from the parental line and MDA-BR clones based on the morphology of suspended and adherent cells, as well as migratory response and PY-paxillin focal adhesion phenotypes on collagen I protein. We speculate that the unique protrusive morphology of the MDA-BO clones may play a role in their ability to establish secondary tumors in the bone tissue. Interestingly, osteocytes, which are the most abundant cell type found in the bone, have long dendritic-like protrusions that radiate into the canaliculi of the bone tissue (<xref ref-type="bibr" rid="B24">Katsimbri, 2017</xref>). Hence, the protrusive morphology of the MDA-BO cells may facilitate their migration and/or formation of osteolytic lesions. Meanwhile, the increased PY-paxillin density in MDA-BO cells may enhance cell adhesion and possibly also proliferation within the bone microenvironment. Since the bone microenvironment is rich in collagen I, a higher focal adhesion density on collagen I would be expected for MDA-BO cells, perhaps due to conditioning which led to upregulation of integrin subtypes with different combinations of the <inline-formula id="inf6">
<mml:math id="m6">
<mml:mi>&#x3b1;</mml:mi>
</mml:math>
</inline-formula> and <inline-formula id="inf7">
<mml:math id="m7">
<mml:mi>&#x3b2;</mml:mi>
</mml:math>
</inline-formula> subunits that promoted adhesion to collagen I (<xref ref-type="bibr" rid="B45">Seong et&#x20;al., 2013</xref>). Furthermore, MDA-BO cell secretion of PTH-rp hormone (<xref ref-type="bibr" rid="B60">Yoneda et&#x20;al., 2001</xref>), which activates bone resorption (<xref ref-type="bibr" rid="B55">Wein and Kronenberg, 2018</xref>), may produce a combinatorial effect, alongside the protrusive morphology and increased focal adhesion density, and to promote bone metastasis. Future work should further explore this combination of phenotypes in identifying risk of bone metastasis in TNBC patients.</p>
<p>Minor differences were found in the adherent and suspended morphology, as well as migration, between the MDA-BR and MDA-P cell line. However, on both glass and 1&#xa0;kPa soft substrates, the MDA-BR cells showed smaller inverse aspect ratio and circularity compared to the parental line. While differences in protein expression (e.g., in the RAS/ERK pathway) have been reported between MDA-BR and MDA-P cell clones (<xref ref-type="bibr" rid="B47">Stark et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B16">Dun et&#x20;al., 2015</xref>), here we found only minor differences in shape-based parameters between the MDA-BR and MDA-P clones. Hence, differences in gene and protein expression may not manifest themselves in physical characteristics such as cell morphology on 2D glass or polyacrylamide gels substrates. Interestingly, in our previous work, there were more significant differences in morphology and migration parameters between MDA-P and MDA-BR cells on 2D hyaluronic acid hydrogels (though trends as a function of crosslinking density were similar between clones; <xref ref-type="bibr" rid="B38">Pranda et&#x20;al., 2019</xref>), suggesting that microenvironment parameters are important considerations when comparing across the organotropic clones. Additionally, a previous study showed that within a MDA-MB-231 population, a bone tropic profile was more easily identifiable compared to a brain tropic line based on cell adhesion and spreading (<xref ref-type="bibr" rid="B6">Barney et&#x20;al., 2015</xref>).</p>
<p>While our goal was to characterize basic phenotypic adhesion and morphology parameters of the organotropic clones, we recognize that a limitation of our work is the simplicity of the microenvironments used in the assays. Future work comparing MDA-BO, MDA-BR, and MDA-P cell clones should be focused on studying other cell behaviors and in different microenvironments. For example, in addition to 2D assays, 3D invasion assays (e.g., into collagen gels) would provide information about physiologically relevant cell behavior in the context of tumor cell metastasis (<xref ref-type="bibr" rid="B9">Baskaran et&#x20;al., 2020</xref>). Second, we propose use of more complex systems for modeling combinatorial cues in physiologically-relevant ECMs, including matrix stiffness, soluble factors, and ECM-bound factors. For example, one study assessed the effects of different combinations of ECM proteins on lung adenocarcinoma cell adhesion and found that metastasized tumor cells have a unique adhesion response to certain proteins and that genetic clustering differs in comparison with cells from the primary tumor site (<xref ref-type="bibr" rid="B40">Reticker-Flynn et&#x20;al., 2012</xref>). Additionally, our study used transformed cell lines that were serially passaged in mice and conditioned to metastasize to specific microenvironments in mice. These cells likely do not represent the heterogeneous metastatic breast cancer cells in humans. Future work would benefit from the use of primary cell lines from patients with brain or bone metastasis to compare the mechanobiological phenotypes, since tumor heterogeneity has been shown to influence cell morphology and migration (<xref ref-type="bibr" rid="B14">Davis et&#x20;al., 2019</xref>).</p>
<p>Overall, we have shown that bone-seeking breast tumor clones have some distinct morphological and migratory phenotypes that could be beneficial for navigating the bone microenvironment, in comparison with the brain-seeking or parental clones. Meanwhile, in the limited microenvironments tested, brain-seeking clone behavior showed only very minor differences from the other cell types. Future work should aim to design systems that encompass more complex combinations of cues from the brain microenvironment, such as shear stress, tortuosity, and surrounding cell types. Additionally, further exploring the link between these physical characteristics and gene and protein expression differences found in previous studies could help establish a full profile for differentiating triple negative organotropic tumor cells in a heterogeneous tumor cell population. The next steps towards development of a diagnostic method for organotropic breast cancer would first include comparison of our results with cells from a primary tumor and metastatic sites in humans. Since our experiments used conditioned, transformed cell lines, it is unknown whether the organotropic clones are easily identifiable in a primary tumor, and human samples. If they are identifiable in a primary tumor, a second step would be to develop an efficient microfluidic device, with proper sensitivity and specificity, for imaging and analyzing tumor cell samples based on the mechanobiological phenotypes, and with a goal of analyzing the presence of organotropic breast cancer cells in a primary tumor sample. Likely, such a device would require launching a large set of experiments, with multiple types of ECM compositions, substrate mechanics, topographies, and other microenvironment features, along with the ability to simultaneously measure multiple mechanobiological and migratory behaviors. Sophisticated multivariable analysis techniques would also likely be needed to identify clustering of specific mechanobiological phenotypes in the organotropic breast cancer cells. Hence, while our data presented here are quite limited in clinical relevance, we anticipate that the work could inspire future work towards a mechanobiological phenotyping approach to identify, and/or predict organotropic breast cancer.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>KS, MP, and AD contributed to conception and design of the study. AD, MP, KG, NG, and MH performed experiments. AD, MP, KG, JM-C, NG, MH, and YZ analyzed data and performed statistical analysis. AD and MP wrote the first draft of the manuscript, and KS edited the manuscript. All authors contributed to manuscript revision, and read and approved the submitted version.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>The authors acknowledge funding from the Clark Doctoral Fellowship (to AD), the Graduate Student Summer Research Fellowship from the UMD Graduate School (to AD), the Burroughs Wellcome Career Award at the Scientific Interface (to KS), NIH grant 2P30CA134274-14 (funds to YZ), the Fischell Fellowship in Biomedical Engineering (to KG), the Ann G. Wylie Fellowship (to MP), and NSF Grant &#x23;1757745 (NG and MH were NSF REU participants on this grant).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors also acknowledge support from the UMD NanoCenter, BioWorkshop, the Fischell Department of Bioengineering, and the University of Maryland.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2022.790410/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2022.790410/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbott</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Yusof</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Structure and Function of the Blood-Brain Barrier</article-title>. <source>Front. Pharmacol.</source> <volume>37</volume> (<issue>1</issue>), <fpage>13</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.3389/conf.fphar.2010.02.00002</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alford</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Kozloff</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Hankenson</surname>
<given-names>K. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Extracellular Matrix Networks in Bone Remodeling</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol.</source> <volume>65</volume>, <fpage>20</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2015.05.008</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ananthanarayanan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Elucidating the Mechanobiology of Malignant Brain Tumors Using a Brain Matrix-Mimetic Hyaluronic Acid Hydrogel Platform</article-title>. <source>Biomaterials</source> <volume>32</volume>, <fpage>7913</fpage>&#x2013;<lpage>7923</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.07.005</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonovaite</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Beekmans</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Wadman</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Iannuzzi</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Regional Variations in Stiffness in Live Mouse Brain Tissue Determined by Depth-Controlled Indentation Mapping</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>12517</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-31035-y</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balzer</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Boggs</surname>
<given-names>A. E.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Physical Confinement Alters Tumor Cell Adhesion and Migration Phenotypes</article-title>. <source>FASEB j.</source> <volume>26</volume>, <fpage>4045</fpage>&#x2013;<lpage>4056</lpage>. <pub-id pub-id-type="doi">10.1096/fj.12-211441</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barney</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Dandley</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Mercurio</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Peyton</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A Cell-ECM Screening Method to Predict Breast Cancer Metastasis</article-title>. <source>Integr. Biol.</source> <volume>7</volume>, <fpage>198</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1039/c4ib00218k</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barney</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Polio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galarza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peyton</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The Predictive Link between Matrix and Metastasis</article-title>. <source>Curr. Opin. Chem. Eng.</source> <volume>11</volume>, <fpage>85</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.coche.2016.01.001</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wischnewsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>St&#xfc;ber</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krockenberger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>H&#xe4;usler</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Pattern of Metastatic Spread and Subcategories of Breast Cancer</article-title>. <source>Arch. Gynecol. Obstet.</source> <volume>295</volume>, <fpage>211</fpage>&#x2013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1007/s00404-016-4225-4</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baskaran</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Weldy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guarin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shpilker</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Kotlik</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cell Shape, and Not 2D Migration, Predicts Extracellular Matrix-Driven 3D Cell Invasion in Breast Cancer</article-title>. <source>APL Bioeng.</source> <volume>4</volume>, <fpage>026105</fpage>. <pub-id pub-id-type="doi">10.1063/1.5143779</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidard</surname>
<given-names>F.-C.</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Fehm</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nol&#xe9;</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gisbert-Criado</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mavroudis</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Clinical Validity of Circulating Tumour Cells in Patients with Metastatic Breast Cancer: A Pooled Analysis of Individual Patient Data</article-title>. <source>Lancet Oncol.</source> <volume>15</volume>, <fpage>406</fpage>&#x2013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(14)70069-5</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brook</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dharmarajan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dass</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Breast Cancer Bone Metastases: Pathogenesis and Therapeutic Targets</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol.</source> <volume>96</volume>, <fpage>63</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2018.01.003</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Boire</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Valiente</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Er</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Lopez-Soto</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Carcinoma-astrocyte gap Junctions Promote Brain Metastasis by cGAMP Transfer</article-title>. <source>Nature</source> <volume>533</volume>, <fpage>493</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1038/nature18268</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cristofanilli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pierga</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Reuben</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rademaker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The Clinical Use of Circulating Tumor Cells (CTCs) Enumeration for Staging of Metastatic Breast Cancer (MBC): International Expert Consensus Paper</article-title>. <source>Crit. Rev. Oncology/Hematology</source> <volume>134</volume>, <fpage>39</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2018.12.004</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Abi Jomaa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Espina</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Liotta</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A New Model Isolates Glioblastoma Clonal Interactions and Reveals Unexpected Modes for Regulating Motility, Proliferation, and Drug Resistance</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-53850-7</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doolin</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Physical Confinement Alters Cytoskeletal Contributions towards Human Mesenchymal Stem Cell Migration</article-title>. <source>Cytoskeleton</source> <volume>75</volume>, <fpage>103</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1002/cm.21433</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dun</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Chalkley</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Faulkner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Keene</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Avery-Kiejda</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis</article-title>. <source>Mol. Cell Proteomics</source> <volume>14</volume>, <fpage>2316</fpage>&#x2013;<lpage>2330</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.m114.046110</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fokas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Engenhart-Cabillic</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Daniilidis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>H.-X.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Metastasis: The Seed and Soil Theory Gains Identity</article-title>. <source>Cancer Metastasis Rev.</source> <volume>26</volume>, <fpage>705</fpage>&#x2013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1007/s10555-007-9088-5</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bado</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. H.-F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metastasis Organotropism: Redefining the Congenial Soil</article-title>. <source>Develop. Cel</source> <volume>49</volume>, <fpage>375</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2019.04.012</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>George</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Extracellular Matrix and Traumatic Brain Injury</article-title>. <source>J.&#x20;Neuro Res.</source> <volume>96</volume>, <fpage>573</fpage>&#x2013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.24151</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Quantitative Phenotyping of Cell-Cell Junctions to Evaluate ZO-1 Presentation in Brain Endothelial Cells</article-title>. <source>Ann. Biomed. Eng.</source> <volume>47</volume>, <fpage>1675</fpage>&#x2013;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-019-02266-5</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilla</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Aranda-Espinoza</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>VE-Cadherin-Independent Cancer Cell Incorporation into the Vascular Endothelium Precedes Transmigration</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e109748</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0109748</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayman</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Danks</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>John Martin</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Localization of Parathyroid Hormone-Related Protein in Breast Cancer Metastases: Increased Incidence in Bone Compared with Other Sites</article-title>. <source>Cancer Res.</source> <volume>51</volume>, <fpage>3059</fpage>&#x2013;<lpage>3061</lpage>. </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahangiri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sidorov</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Yagnik</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rick</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Cross-activating C-Met/&#x3b2;1 Integrin Complex Drives Metastasis and Invasive Resistance in Cancer</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>114</volume>, <fpage>E8685</fpage>&#x2013;<lpage>E8694</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1701821114</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsimbri</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Biology of normal Bone Remodelling</article-title>. <source>Eur. J.&#x20;Cancer Care</source> <volume>26</volume>, <fpage>e12740</fpage>. <pub-id pub-id-type="doi">10.1111/ecc.12740</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koniali</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hadjisavvas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Constantinidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Christou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Demetriou</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Risk Factors for Breast Cancer Brain Metastases: a Systematic Review</article-title>. <source>Oncotarget</source> <volume>11</volume>, <fpage>650</fpage>&#x2013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.27453</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Cua</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Keough</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Haylock-Jacobs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>V. W.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pathophysiology of the Brain Extracellular Matrix: A New Target for Remyelination</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>14</volume>, <fpage>722</fpage>&#x2013;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3550</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>W&#xfc;rges</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schicht</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Br&#xe4;uer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cyron</surname>
<given-names>C. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Unraveling the Local Relation between Tissue Composition and Human Brain Mechanics through Machine Learning</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>9</volume>, <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2021.704738</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lisovicz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wynn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fouad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Partridge</surname>
<given-names>E. E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Cancer Health Disparities: what We Have Done</article-title>. <source>Am. J.&#x20;Med. Sci.</source> <volume>335</volume>, <fpage>254</fpage>&#x2013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1097/MAJ.0b013e31816a43ad</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McFarlane</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McFarlane</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Waugh</surname>
<given-names>D. J.&#x20;J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>CD44-mediated Activation of &#x3b1;5&#x3b2;1-integrin, Cortactin and Paxillin Signaling Underpins Adhesion of Basal-like Breast Cancer Cells to Endothelium and Fibronectin-Enriched Matrices</article-title>. <source>Oncotarget</source> <volume>6</volume>, <fpage>36762</fpage>&#x2013;<lpage>36773</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.5461</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Oza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arriaga</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez Hern&#xe1;ndez</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Rotello</surname>
<given-names>V. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Triple-negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies</article-title>. <source>Int. J.&#x20;Environ. Res. Public Health</source> <volume>17</volume>, <fpage>2078</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17062078</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mentis</surname>
<given-names>A.-F. A.</given-names>
</name>
<name>
<surname>Grivas</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Dardiotis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Romas</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Papavassiliou</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Circulating Tumor Cells as Trojan Horse for Understanding, Preventing, and Treating Cancer: a Critical Appraisal</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>77</volume>, <fpage>3671</fpage>&#x2013;<lpage>3690</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-020-03529-4</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mierke</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fellner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fabry</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Integrin &#x3b1;5&#x3b2;1 Facilitates Cancer Cell Invasion through Enhanced Contractile Forces</article-title>. <source>J.&#x20;Cel Sci.</source> <volume>124</volume>, <fpage>369</fpage>&#x2013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.071985</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Koolstra</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>den Toonder</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>van Eijden</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Relationship between Tissue Stiffness and Degree of Mineralization of Developing Trabecular Bone</article-title>. <source>J.&#x20;Biomed. Mater. Res.</source> <volume>84A</volume>, <fpage>508</fpage>&#x2013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.31474</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xfc;ller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Homey</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Soto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Catron</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>M. E.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Involvement of Chemokine Receptors in Breast Cancer Metastasis</article-title>. <source>Nature</source> <volume>410</volume>, <fpage>50</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/35065016</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narkhede</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Crenshaw</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Influence of Matrix Stiffness on the Behavior of Brain Metastatic Breast Cancer Cells in a Biomimetic Hyaluronic Acid Hydrogel Platform</article-title>. <source>J.&#x20;Biomed. Mater. Res.</source> <volume>106</volume>, <fpage>1832</fpage>&#x2013;<lpage>1841</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.36379</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H.-A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Cellular Mechanisms of Circulating Tumor Cells during Breast Cancer Metastasis</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>21</volume>, <fpage>5040</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21145040</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Partridge</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Ottesen</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>Y.-N.</given-names>
</name>
<name>
<surname>Edge</surname>
<given-names>S. B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Subtype-dependent Relationship between Young Age at Diagnosis and Breast Cancer Survival</article-title>. <source>J.&#x20;Clin. Oncol.</source> <volume>34</volume>, <fpage>3308</fpage>&#x2013;<lpage>3314</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2015.65.8013</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pranda</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>DeCastro</surname>
<given-names>A. J.&#x20;L.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tumor Cell Mechanosensing during Incorporation into the Brain Microvascular Endothelium</article-title>. <source>Cel. Mol. Bioeng.</source> <volume>12</volume>, <fpage>455</fpage>&#x2013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1007/s12195-019-00591-2</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Dejesus</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Short</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Otero</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>J.&#x20;O.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Glioblastoma Behaviors in Three-Dimensional Collagen-Hyaluronan Composite Hydrogels</article-title>. <source>ACS Appl. Mater. Inter.</source> <volume>5</volume>, <fpage>9276</fpage>&#x2013;<lpage>9284</lpage>. <pub-id pub-id-type="doi">10.1021/am402097j</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reticker-Flynn</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Malta</surname>
<given-names>D. F. B.</given-names>
</name>
<name>
<surname>Winslow</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Lamar</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>G. H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>A Combinatorial Extracellular Matrix Platform Identifies Cell-Extracellular Matrix Interactions that Correlate with Metastasis</article-title>. <source>Nat. Commun.</source> <volume>3</volume>, <fpage>1122</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms2128</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riebensahm</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Joosse</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Mohme</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matschke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goy</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Clonality of Circulating Tumor Cells in Breast Cancer Brain Metastasis Patients</article-title>. <source>Breast Cancer Res.</source> <volume>21</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13058-019-1184-2</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schor</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Cell Migration through Three-Dimensional Gels of Native Collagen Fibres: Collagenolytic Activity Is Not Required for the Migration of Two Permanent Cell Lines</article-title>. <source>J.&#x20;Cel Sci</source> <volume>46</volume>, <fpage>171</fpage>&#x2013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.46.1.171</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schor</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Cell Proliferation and Migration on Collagen Substrata <italic>In Vitro</italic>
</article-title>. <source>J.&#x20;Cel Sci</source> <volume>41</volume>, <fpage>159</fpage>&#x2013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.41.1.159</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Mobley</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Il&#x2019;yasova</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Update on Triple-Negative Breast Cancer Disparities for the United&#x20;States: A Population-Based Study from the United&#x20;States Cancer Statistics Database, 2010 through 2014</article-title>. <source>Cancer</source> <volume>125</volume>, <fpage>3412</fpage>&#x2013;<lpage>3417</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.32207</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tajik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Distinct Biophysical Mechanisms of Focal Adhesion Kinase Mechanoactivation by Different Extracellular Matrix Proteins</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume>, <fpage>19372</fpage>&#x2013;<lpage>19377</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1307405110</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shumakovich</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mencio</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Siglin</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Moriarty</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Astrocytes from the Brain Microenvironment Alter Migration and Morphology of Metastatic Breast Cancer Cells</article-title>. <source>FASEB J.</source> <volume>31</volume>, <fpage>5049</fpage>&#x2013;<lpage>5067</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700254R</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stark</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Anuszkiewicz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mentlein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yoneda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mehdorn</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Held-Feindt</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Differential Expression of Matrix Metalloproteinases in Brain- and Bone-Seeking Clones of Metastatic MDA-MB-231 Breast Cancer Cells</article-title>. <source>J.&#x20;Neurooncol.</source> <volume>81</volume>, <fpage>39</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-006-9207-0</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoletov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zardouzian</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kelber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shattil</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Visualizing Extravasation Dynamics of Metastatic Tumor Cells</article-title>. <source>J.&#x20;Cel Sci.</source> <volume>123</volume>, <fpage>2332</fpage>&#x2013;<lpage>2341</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.069443</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Aranda-Espinoza</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Endothelial Cell Substrate Stiffness Influences Neutrophil Transmigration via Myosin Light Chain Kinase-dependent Cell Contraction</article-title>. <source>Blood</source> <volume>118</volume>, <fpage>1632</fpage>&#x2013;<lpage>1640</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-11-321125</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Aranda-Espinoza</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Neutrophils Display Biphasic Relationship between Migration and Substrate Stiffness</article-title>. <source>Cell Motil. Cytoskeleton</source> <volume>66</volume>, <fpage>328</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1002/cm.20363</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Konstantopoulos</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Physical Biology in Cancer. 4. Physical Cues Guide Tumor Cell Adhesion and Migration</article-title>. <source>Am. J.&#x20;Physiol. Physiol.</source> <volume>306</volume>, <fpage>C98</fpage>&#x2013;<lpage>C109</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00289.2013</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroka</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Levitan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aranda-Espinoza</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>OxLDL and Substrate Stiffness Promote Neutrophil Transmigration by Enhanced Endothelial Cell Contractility and ICAM-1</article-title>. <source>J.&#x20;Biomech.</source> <volume>45</volume>, <fpage>1828</fpage>&#x2013;<lpage>1834</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiomech.2012.04.011</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Pelham</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>[39] Preparation of a Flexible, Porous Polyacrylamide Substrate for Mechanical Studies of Cultured Cells</article-title>. <source>Methods Enzymol.</source> <volume>298</volume>, <fpage>489</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(98)98041-7</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>R. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Biology of Bone: The Vasculature of the Skeletal System</article-title>. <source>Cold Spring Harb. Perspect. Med.</source> <volume>8</volume>, <fpage>a031559</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a031559</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wein</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Kronenberg</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Regulation of Bone Remodeling by Parathyroid Hormone</article-title>. <source>Cold Spring Harb. Perspect. Med.</source> <volume>8</volume>, <fpage>a031237</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a031237</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Gilkes</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Phillip</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Narkar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T. W. T.</given-names>
</name>
<name>
<surname>Marchand</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Single-cell Morphology Encodes Metastatic Potential</article-title>. <source>Sci. Adv.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/sciadv.aaw6938</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Phillip</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Khatau</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Stirman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rosseel</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Evolution of Cellular Morpho-Phenotypes in Cancer Metastasis</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/srep18437</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yankaskas</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Vitolo</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Mistriotis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mahendra</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Microfluidic Assay for the Quantification of the Metastatic Propensity of Breast Cancer Specimens</article-title>. <source>Nat. Biomed. Eng.</source> <volume>3</volume>, <fpage>452</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-019-0400-9</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Selander</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chirgwin</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Dallas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grubbs</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Wieser</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>TGF-&#x3b2; Signaling Blockade Inhibits PTHrP Secretion by Breast Cancer Cells and Bone Metastases Development</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>103</volume>, <fpage>197</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1172/JCI3523</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoneda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Hiraga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Niewolna</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>A Bone-Seeking Clone Exhibits Different Biological Properties from the MDA-MB-231 Parental Human Breast Cancer Cells and a Brain-Seeking Clone <italic>In Vivo</italic> and <italic>In Vitro</italic>
</article-title>. <source>J.&#x20;Bone Miner. Res.</source> <volume>16</volume>, <fpage>1486</fpage>&#x2013;<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.2001.16.8.1486</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>